Tag Archives: ADHD Therapeutics Market Share

Attention Deficit/Hyperactivity Disorder (ADHD) is a psychiatric disorder with an estimated global prevalence of 5.3% in children and adolescents. Diagnosis most commonly occurs in children, but the importance of identifying ADHD in the adult population has risen in the past decade. However, diagnosis remains difficult due to unknown genetic causes and a lack of accurateContinue reading “Global ADHD Therapeutics Industry Research: Key Companies Profile with Sales, Revenue, Market Share, Price and Competitive Situation Analysis”

Attention Deficit/Hyperactivity Disorder (ADHD) is a psychiatric disorder with an estimated global prevalence of 5.3% in children and adolescents. Diagnosis most commonly occurs in children, but the importance of identifying ADHD in the adult population has risen in the past decade. However, diagnosis remains difficult due to unknown genetic causes and a lack of accurateContinue reading “Global ADHD Therapeutics Industry Report: Product Scope, Overview, Market Opportunities, Driving Forces and Risk Analysis”